J.-F. Lefebvre, D. Leclercq, J.-P. Gisselbrecht, S. Richeter
FULL PAPER
azole), 7.90–7.75 (br. s, 4 H, Armeta), 7.72 (d, J = 8.2 Hz, 4 H,
Armeta), 1.62 (br. s, 18 H, tBu), 1.59 (s, 18 H, tBu) ppm. UV/Vis
(CH2Cl2): λ (ε, Lmol–1 cm–1) = 419 (248600), 531 (14500), 568
pentane afforded 19 in 86% yield (171 mg). 1H NMR (200 MHz,
CDCl3 + 10% CD3OD, 25 °C): δ = 8.86 (d, J = 4.6 Hz, 2 H, pyr-
role), 8.83 (s, 2 H, pyrrole), 8.71 (d, J = 4.6 Hz, 2 H, pyrrole), 8.03
(7700) nm. MS (FAB+): m/z
=
935 [NiC61H61N6+]. (d, J = 8.1 Hz, 4 H, Arortho), 7.95 (d, J = 8.0 Hz, 4 H, Arortho), 7.64
C61H60N6Ni·H2O (953.88): calcd. C 76.81, H 6.55, N 8.81; found
C 77.13, H 6.48, N 8.90.
(d, J = 8.0 Hz, 4 H, Armeta), 7.61 (d, J = 8.1 Hz, 4 H, Armeta), δ =
7.51 (s, 1 H, CH imidazole), 1.53 (s, 36 H, tBu) pm ppm. UV/Vis
(CH2Cl2): λ (ε, Lmol–1 cm–1) = 424 (554000), 551 (20900), 590
Nickel Bis(formamide) 16: 1H NMR (200 MHz, CDCl3, 25 °C): δ
= 8.75 (s, 2 H, pyrrole), 8.73 (s, 4 H, pyrrole), 7.94 (d, J = 7.9 Hz,
4 H, Arortho), 7.87 (m, 4 H, Arortho), 7.75 (br. s, 2 H, CHO), 7.71
(d, J = 7.5 Hz, 8 H, Armeta), 7.09 (br. s, 2 H, NH), 1.47 (s, 18 H,
tBu), 1.46 (s, 18 H, tBu) ppm. UV/Vis (CH2Cl2): λ (ε, Lmol–1 cm–1)
(9800) nm. MS (ESI+): m/z
=
941.5 [ZnC61H61N6+].
C61H60N6Zn·H2O (960.59): calcd. C 76.27, H 6.51, N 8.75; found
C 76.46, H 6.43, N 8.90.
Copper Imidazole 20: Free-base imidazole 18 (400 mg,
4.55ϫ10–4 mol) was mixed with Cu(OAc)2·2H2O (220 mg,
1.10ϫ10–3 mol) in CHCl3/methanol (40/5 mL). The mixture was
heated at reflux for 12 h. After solvent evaporation and purification
by silica gel column chromatography (CH2Cl2), crystallization from
CH2Cl2/methanol afforded 20 in 91% yield (390 mg). UV/Vis
(CH2Cl2): λ (ε, Lmol–1 cm–1) = 417 (418300), 538 (19100), 575
= 424 (232100), 538 (17400) nm. IR (KBr): ν = 1704 (CO) cm–1.
˜
MS (ESI+): m/z
=
981.3 [NiC62H63N6O2+]. C62H62N6NiO2
(981.89): calcd. C 75.84, H 6.36, N 8.56; found C 75.73, H 6.41, N
8.50.
Nickel Monoformamide 17:
A
solution of 11 (500 mg,
5.23ϫ10–4 mol) and palladium on activated carbon (10%, 20 mg,
1.88ϫ10–4 mol) in a mixture of dichloromethane (125 mL) and
methanol (15 mL) was prepared and degassed. Sodium borohyd-
ride (500 mg, 1.32ϫ10–2 mol) was added, and the solution was
stirred under an atmosphere of argon for 1 h. Completion of the
reduction was verified by silica gel TLC (one red spot correspond-
ing to 2,3-diaminoporphyrin 13). After evaporation of the solvents,
formic acid (2.5 mL) and toluene (47.5 mL) were added to the resi-
due, and the reaction mixture was heated at reflux under an atmo-
sphere of argon for 2 h. After cooling, the mixture was neutralized
with K2CO3, washed with water (3ϫ), and concentrated. The resid-
ual mixture was purified by silica gel column chromatography
(CH2Cl2). The first fraction containing a mixture of brown nonpo-
lar unidentified compounds was eliminated. The second fraction
contained red 17, followed by trace amounts of 15. Trace amounts
of bis(formamide) can be eluted with CH2Cl2/MeOH, 95:5. After
evaporation of the solvents and crystallization from CH2Cl2/
MeOH, monoformamide 17 was obtained as a purple solid in 58%
(8300) nm. MS (ESI+): m/z
=
940.0 [CuC61H61N6+].
CuC61H60N6·2H2O (976.75): calcd. C 75.01, H 6.60, N 8.60; found
C 74.94, H 6.52, N 8.66.
Nickel Imidazolium Salt 21 (Alkylation with Iodomethane): Nickel
imidazole 15 (125 mg, 1.33ϫ10–4 mol) was dissolved in acetone
(30 mL). Iodomethane (5 mL) and K2CO3 (0.5 g) were added, and
the solution was stirred at 40 °C under an atmosphere of argon for
24 h. Completion of the alkylation was verified by silica gel TLC,
and the solvent was evaporated. The residue was purified by silica
gel column chromatography (CH2Cl2 to CH2Cl2/MeOH, 95:5).
Nickel imidazolium salt 15 was the most polar compound.
Crystallization from pentane afforded 21 in 81% yield (116 mg).
1H NMR (200 MHz, CDCl3, 25 °C): δ = 11.07 (s, 1 H, CH imid-
azolium), 8.78 (s, 2 H, pyrrole), 8.75 (d, J = 5.0 Hz, 2 H, pyrrole),
8.70 (d, J = 5.0 Hz, 2 H, pyrrole), 8.09 (d, J = 8.3 Hz, 4 H, Arortho),
7.99 (d, J = 8.3 Hz, 4 H, Arortho), 7.84 (d, J = 8.3 Hz, 4 H, Armeta),
7.76 (d, J = 8.3 Hz, 4 H, Armeta), 3.30 (s, 6 H, methyl), 1.60 (s, 18
H, tBu), 1.59 (s, 18 H, tBu) ppm. UV/Vis (CH2Cl2): λ (ε,
Lmol–1 cm–1) = 425 (276100), 537 (18000), 575 (sh., 3800) nm. MS
(FAB+): m/z = 963 [NiC63H65N6+]. C63H65IN6Ni·H2O (1109.84):
calcd. C 68.18, H 6.08, I 11.43, N 7.57; found C 67.48, H 6.05, I
11.19, N 7.55.
1
yield (290 mg). H NMR (200 MHz, CDCl3, 25 °C): δ = 8.75 (m,
6 H, pyrrole), 7.90 (m, 8 H, Arortho), 7.85 (br. s, 1 H, CHO), 7.77
(m, 8 H, Armeta), 7.07 (br. s, 1 H, NH), 6.99 (br. s, 2 H, NH2), 1.58
(s, 36H tBu), 1.57 (s, 36 H, tBu) ppm. λ (ε, Lmol–1 cm–1) = 419
(211000), 538 (14600), 580 (7500) nm. IR (KBr): ν = 1704 (CO),
˜
3389, 3457 (NH2) cm–1. MS (ESI+): m/z = 953.0 [NiC61H63N6O+].
C61H62N6NiO (953.88): calcd. C 76.81, H 6.55, N 8.81; found C
75.07, H 6.63, N 8.26.
Zinc Imidazolium Salt 22: Same procedure as for 21. Zinc imid-
azolium salt 22 was obtained in 80% yield. 1H NMR (200 MHz,
CDCl3, 25 °C): δ = 10.17 (br. s, 1 H, CH imidazolium), 8.93 (s, 2
H, pyrrole), 8.92 (d, J = 4.8 Hz, 2 H, pyrrole), 8.81 (d, J = 4.7 Hz,
2 H, pyrrole), 8.29 (d, J = 8.2 Hz, 4 H, Arortho), 8.13 (d, J = 8.1 Hz,
4 H, Arortho), 7.85 (d, J = 8.2 Hz, 4 H, Armeta), 7.77 (d, J = 7.9 Hz,
4 H, Armeta), 3.22 (s, 6 H, methyl), 1.63 (s, 18 H, tBu), 1.62 (s, 18
H, tBu) ppm. UV/Vis (CH2Cl2): λ (ε, Lmol–1 cm–1) = 432 (463900),
Free-Base Imidazole 18: Nickel imidazole 15 (460 mg,
4.91ϫ10–4 mol) was dissolved in TFA/H2SO4 (16/4 mL), and the
solution was stirred at room temperature for 30 min. It was then
poured on ice, diluted with chloroform (200 mL), neutralized with
saturated K2CO3, washed with water, dried (Na2SO4), and concen-
trated. Crystallization from CH2Cl2/MeOH afforded 18 in 95%
yield (410 mg). 1H NMR (200 MHz, CDCl3, 25 °C): δ = 9.00 (d, J
= 4.8 Hz, 2 H, pyrrole), 8.88 (d, J = 4.8 Hz, 2 H, pyrrole), 8.85 (s,
2 H, pyrrole), 8.22 (d, J = 8.3 Hz, 4 H, Arortho), 8.20 (d, J = 8.3 Hz,
4 H, Arortho), 8.01 (s, 1 H, CH imidazole), 7.90 (d, J = 8.2 Hz, 4
H, Armeta), 7.80 (d, J = 8.3 Hz, 4 H, Armeta), 1.69 (s, 18 H, tBu),
1.65 (s, 18 H, tBu), –2.89 (s, 2 H, internal NH) ppm. UV/Vis
(CH2Cl2): λ (ε, Lmol–1 cm–1) = 420 (350800), 516 (16200), 552
(9400), 587 (7100), 644 (3180) nm. MS (ESI+): m/z = 879.5
[C61H63N6+].
563 (18250), 608 (7800) nm. MS (ESI+): m/z
= 969.5
[ZnC63H65N6+]. C63H65IN6Zn·H2O (1116.56): calcd. C 67.77, H
6.05, N 7.53; found C 67.41, H 6.02, N 7.54.
Copper Imidazolium Salt 23: Same procedure as for 21. Copper
imidazolium salt 23 was obtained in 60% yield. UV/Vis (CH2Cl2):
λ (ε, Lmol–1 cm–1) = 425 (331200), 547 (17700), 584 (4200) nm. MS
(ESI+): m/z = 968.5 [CuC63H65N6+]. C63H65CuIN6 (1096.68): calcd.
C 69.00, H 5.97, N 7.66; found C 68.89, H 6.38, N 7.67.
Free-Base Imidazolium Salt 24: Same procedure as for 21. Free-
base imidazolium salt 24 was obtained in 83% yield. 1H NMR
Zinc Imidazole 19: Free-base imidazole 18 (185 mg, (200 MHz, CDCl3, 25 °C): δ = 10.77 (s, 1 H, CH imidazolium),
2.10ϫ10–4 mol) was mixed with Zn(OAc)2·2H2O (100 mg, 8.98 (s, 4 H, pyrrole), 8.79 (s, 2 H, pyrrole), 8.43 (d, J = 8.2 Hz, 4
4.46ϫ10–4 mol) in toluene (25 mL). The mixture was heated at re-
flux for 2 h. After solvent evaporation and purification by silica gel
column chromatography (CH2Cl2), crystallization from CH2Cl2/
H, Arortho), 8.23 (d, J = 8.2 Hz, 4 H, Arortho), 7.97 (d, J = 8.3 Hz,
4 H, Armeta), 7.86 (d, J = 8.3 Hz, 4 H, Armeta), 3.27 (s, 6 H, methyl),
1.66 (s, 18 H, tBu), 1.64 (s, 18 H, tBu), –2.94 (s, 2 H, internal NH)
1918
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 1912–1920